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Insomnia surpasses other illness in prevalence (40–50%
population), influence on life, economic and time losses.
Pharmacotherapy is the most widespread method of in-
somnia therapy and prophylaxis. There are 28 hypnotic
drugs approved for use throughout Russia. These drugs
are equally effective and distinguished by frequency and
severity of adverse events, effects on quality of life, and
costs. The number of corresponding trials was insufficient
to make the quantitative comparison of these parameters.
We have classified the hypnotic drugs by their ascending
side effects and their descending quality of life into the fol-
lowing sequence: imovan (cyclopyrrolon) and ivadal (imida-
zopyridine), benzodiazepine (22), Donormyl (ethanola-
mine), barbiturates (3). Benzodiazepines are commonly
used drugs which accounted for their low costs, high effec-
tiveness, and prescribing habits. The next generation drugs,
imovan and ivadal, do not have the same sales and required
active promotion, both of which were complicated by the fi-
nancial crash during 1998. As we proposed, benzodiaz-
epines from CIS and Eastern Europe will be the most used
hypnotic drugs during the next 2 years in Russia.
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OBJECTIVE: To quantify the extent to which, from a
managed care perspective, future short-term healthcare
costs are impacted by current alcohol consumption and
smoking.
METHODS: Data for a random sample of 12,185 adult
patients from the Kaiser Permanente Patient Consulta-
tion Study (1992–1995) were used in this analysis. Using
multivariate predictive models, the logarithm of total
healthcare costs over 2 years was regressed on patient-
specific demographic and health status variables as mea-
sured in the baseline year, including measures of comor-
bidity. Alcohol consumption and smoking behaviors
were measured by self-report at baseline. Considering the
skewness of cost distribution, nonparametric tests were
also performed on the models.
RESULTS: Alcohol consumption proved statistically sig-
nificant in reducing total healthcare costs in the basic
model (14.97%, p  0.0001, R2  0.1413). However,
smoking was not found to statistically affect healthcare
costs in the basic regression model. These results were ro-
bust with respect to respecifications of the model that in-
cluded prior costs, levels of smoking and drinking, and the
presence of chronic disease states. Other covariates found
to significantly increase costs were age, female, single or
separated marital status, and being disabled. Compared to
White patients, Asian, Black, and Latino patients incurred
significantly lower healthcare costs in all models.
CONCLUSION: Results from this analysis showed a
negative relationship between alcohol consumption and
short-term healthcare costs while smoking was not found
to affect future costs. However, further studies are neces-
sary to focus on the history of health-related behaviors
rather than current patterns to more closely establish a
link between smoking and drinking and healthcare costs.
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OBJECTIVE: Effective asthma management requires in-
formed active involvement of patients and physicians.
One aspect, physician clinical knowledge, was evaluated
in this study as part of a comprehensive disease manage-
ment strategy to improve the quality of asthma care in a
managed care setting. 
METHODS: A pulmonologist administered a standard-
ized telephone interview to 68 primary care physicians
(72% participation rate). Participants were selected from
a random sample of HMO physicians with at least one
medical or pharmacy claim for asthma in the 6 months
prior to interview. The interview tested basic clinical
knowledge and specific applications of knowledge as out-
lined in the 1997 NIH/NHLBI Guidelines for the Diag-
nosis and Management of Asthma and covered: initial
asthma assessment and diagnosis; pharmacologic ther-
apy; control of factors contributing to asthma severity;
and patient management and education. Each domain
contributed 25 points to the overall score of 100 points. 
RESULTS: The mean overall score among the 68 partici-
pating physicians was 46  9. Overall, domain specific
scores were low. Knowledge regarding environmental
and non-environmental asthma triggers and commonly
recommended control measures was poor. More than
half under-assessed asthma severity based on symptoms
and pulmonary function. Almost 75% incorrectly stated
the indications for the use of long-acting inhaled beta2-
agonists. Almost half did not develop written action
plans with patients for asthma self-management. 
CONCLUSIONS: This survey revealed several key limi-
tations in physicians’ asthma knowledge. These limita-
tions will be addressed in a targeted and tailored physi-
cian educational intervention.
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